The FDA has approved datopotamab deruxtecan (Dato-DXd, Datroway, Daiichi Sankyo) for the treatment of patients with ...

A cohort study of births in Brazil found increased hospitalization risk through age 3 after maternal chikungunya; results ...

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than ...

The conditional authorization covers adults and children aged 2 years and older with severe or life-threatening ...

Dr Sunnie Kim previews key GI trials highlighting novel bispecific antibodies, dual immunotherapy combinations, KIT ...

Novel CRISPR-Cas9 treatments are proving effective in reversing disease for life. But ensuring their long-term safety will ...

Insomnia, sleepiness, fatigue, and stress were associated with higher depression scores, but caffeine appeared to lessen the ...

Insights from ASCO 2026, including anticipated presentations, key takeaways, and how emerging research in GI cancers may affect patient care.

Emerging evidence suggests that leptin, dysbiosis, and altered innate immunity may contribute to poor asthma control in ...

The Fracture Risk Assessment Tool predictions suggest patients who don’t meet guideline criteria for parathyroidectomy may ...

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline ...

An early evaluation of 'Swap to Stop' scheme in England shows a 4-week quit rate of 34.3% among recipients of free ...